URS
REGN icon

Utah Retirement Systems’s Regeneron Pharmaceuticals REGN Stock Holding History

Utah Retirement Systems’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.57M Sell
15,346
-1,146
-7% -$780K 0.09% 200
2026
Q1 		$12.7M Sell
16,492
-580
-3% -$444K 0.13% 141
2025
Q4 		$13.2M Sell
17,072
-153
-0.9% -$104K 0.13% 140
2025
Q3 		$9.69M Buy
17,225
+23
+0.1% +$13K 0.09% 194
2025
Q2 		$9.03M Sell
17,202
-120
-0.7% -$67K 0.09% 200
2025
Q1 		$11M Hold
17,322
– – 0.13% 154
2024
Q4 		$12.3M Buy
17,322
+30
+0.2% +$25.2K 0.14% 142
2024
Q3 		$18.2M Buy
17,292
+64
+0.4% +$71.2K 0.21% 93
2024
Q2 		$18.1M Sell
17,228
-527
-3% -$511K 0.22% 89
2024
Q1 		$17.1M Sell
17,755
-14
-0.1% -$13.3K 0.2% 101
2023
Q4 		$15.6M Sell
17,769
-61
-0.3% -$50.2K 0.2% 108
2023
Q3 		$14.7M Buy
17,830
+42
+0.2% +$33K 0.21% 96
2023
Q2 		$12.8M Sell
17,788
-668
-4% -$515K 0.18% 115
2023
Q1 		$15.2M Buy
18,456
+45
+0.2% +$33.9K 0.22% 95
2022
Q4 		$13.3M Sell
18,411
-175
-0.9% -$129K 0.21% 106
2022
Q3 		$12.8M Buy
18,586
+91
+0.5% +$57.3K 0.21% 97
2022
Q2 		$10.9M Buy
18,495
+247
+1% +$161K 0.18% 120
2022
Q1 		$12.7M Buy
18,248
+100
+0.6% +$63.3K 0.17% 114
2021
Q4 		$11.5M Buy
18,148
+41
+0.2% +$25.2K 0.14% 136
2021
Q3 		$11M Sell
18,107
-953
-5% -$592K 0.15% 133
2021
Q2 		$10.6M Buy
19,060
+558
+3% +$283K 0.14% 145
2021
Q1 		$8.75M Sell
18,502
-800
-4% -$389K 0.12% 160
2020
Q4 		$9.32M Buy
19,302
+800
+4% +$432K 0.13% 150
2020
Q3 		$10.4M Buy
18,502
+100
+0.5% +$60.6K 0.17% 122
2020
Q2 		$11.5M Buy
18,402
+2,850
+18% +$1.62M 0.21% 97
2020
Q1 		$7.59M Hold
15,552
– – 0.16% 126
2019
Q4 		$5.84M Hold
15,552
– – 0.1% 194
2019
Q3 		$4.31M Buy
15,552
+100
+0.6% +$29.6K 0.08% 247
2019
Q2 		$4.84M Buy
15,452
+194
+1% +$64.6K 0.09% 221
2019
Q1 		$6.26M Buy
15,258
+484
+3% +$199K 0.12% 175
2018
Q4 		$5.52M Hold
14,774
– – 0.12% 173
2018
Q3 		$5.97M Hold
14,774
– – 0.12% 183
2018
Q2 		$5.1M Hold
14,774
– – 0.11% 198
2018
Q1 		$5.09M Hold
14,774
– – 0.11% 198
2017
Q4 		$5.55M Buy
14,774
+400
+3% +$162K 0.12% 185
2017
Q3 		$6.43M Hold
14,374
– – 0.14% 152
2017
Q2 		$7.06M Buy
14,374
+122
+0.9% +$53.4K 0.16% 131
2017
Q1 		$5.52M Hold
14,252
– – 0.13% 169
2016
Q4 		$5.23M Hold
14,252
– – 0.13% 169
2016
Q3 		$5.73M Hold
14,252
– – 0.15% 148
2016
Q2 		$4.98M Buy
14,252
+100
+0.7% +$38.5K 0.13% 164
2016
Q1 		$5.1M Hold
14,152
– – 0.14% 157
2015
Q4 		$7.68M Buy
14,152
+100
+0.7% +$54.2K 0.21% 103
2015
Q3 		$6.54M Hold
14,052
– – 0.19% 118
2015
Q2 		$7.17M Sell
14,052
-100
-0.7% -$48.8K 0.19% 113
2015
Q1 		$6.39M Buy
14,152
+500
+4% +$212K 0.17% 128
2014
Q4 		$5.6M Hold
13,652
– – 0.15% 142
2014
Q3 		$4.92M Sell
13,652
-100
-0.7% -$33.5K 0.14% 151
2014
Q2 		$3.88M Sell
13,752
-700
-5% -$207K 0.11% 196
2014
Q1 		$4.34M Buy
14,452
+100
+0.7% +$30.8K 0.13% 177
2013
Q4 		$3.95M Hold
14,352
– – 0.12% 185
2013
Q3 		$4.49M Sell
14,352
-100
-0.7% -$26.3K 0.15% 144
2013
Q2 		$3.25M Buy
+14,452
New +$3.37M 0.11% 198

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Utah Retirement Systems's REGN Position: Q2 2026 in Review

Utah Retirement Systems reduced its Regeneron Pharmaceuticals (REGN) stake by 6.9% in Q2 2026, selling an estimated $780K and leaving 15,346 shares worth $9.57M. The position accounts for 0.09% of the portfolio, ranked #200.

Utah Retirement Systems first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.2M in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Utah Retirement Systems held 15,346 shares of Regeneron Pharmaceuticals worth $9.57M as of Q2 2026.
  • Utah Retirement Systems sold 1,146 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $780K.
  • Regeneron Pharmaceuticals made up 0.09% of Utah Retirement Systems's portfolio in Q2 2026, its #200 holding.
  • Utah Retirement Systems first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Utah Retirement Systems's Regeneron Pharmaceuticals position peaked at $18.2M in Q3 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.